Minerva Neuroscie (NERV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 68,975 | 83,061 | 91,933 | 88,750 | 34,902 |
| Marketable Securities | 16,465 | N/A | N/A | 8,387 | 9,818 |
| TOTAL | $86,231 | $83,864 | $92,635 | $97,416 | $45,338 |
| Non-Current Assets | |||||
| PPE Net | 34,206 | 34,210 | 34,213 | 34,218 | 34,222 |
| Intangibles | 14,869 | 14,869 | 14,869 | 14,869 | 14,869 |
| TOTAL | $49,076 | $49,079 | $49,083 | $49,087 | $49,091 |
| Total Assets | $135,307 | $132,943 | $141,718 | $146,502 | $94,429 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,275 | 1,468 | 833 | 877 | 1,224 |
| Accrued Expenses | 4,752 | 3,364 | 4,515 | 1,483 | 3,102 |
| TOTAL | $12,986 | $9,686 | $10,099 | $6,238 | $6,970 |
| Non-Current Liabilities | |||||
| Long Term Debt | 2,601 | 3,841 | 5,049 | 6,225 | 7,376 |
| TOTAL | $16,034 | $17,275 | $18,483 | $19,659 | $20,810 |
| Total Liabilities | $29,020 | $26,961 | $28,581 | $25,897 | $27,779 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 4,588 | 4,411 | 4,351 | 4,351 | 3,493 |
| Common Shares | 4 | 4 | 4 | 4 | 3 |
| Retained earnings | -143,503 | -132,858 | -123,454 | -115,031 | -109,817 |
| TOTAL | $106,286 | $105,982 | $113,137 | $120,605 | $66,650 |
| Total Liabilities And Equity | $135,307 | $132,943 | $141,718 | $146,502 | $94,429 |